Jan Müller‐Brand

2 ta ish

Institute of Nuclear Medicine, Aarau, Switzerland

1. Interfemur Variation of Bone Mineral Density in Patients Receiving High-dose Thyroxin Therapy

   Gerhard W. Goerres, R. Theiler, Jan Müller‐Brand

   MaqolaBone health and osteoporosis researchCalcified Tissue International19980 iqtibos

   ABIABI:AkademIndex/openalex/1998.article.000074

2. Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical Trial

   Fabienne Iten, Beat P. Müller‐Stich, Christian Schindler +5

   MaqolaThyroid Cancer Diagnosis and TreatmentClinical Cancer Research20070 iqtibos

   ABIABI:AkademIndex/openalex/2007.article.000008